Cargando…

Incidence of Medically Attended Respiratory Syncytial Virus and Influenza Illnesses in Children 6–59 Months Old During Four Seasons

Background. Respiratory syncytial virus (RSV) and influenza are significant causes of seasonal respiratory illness in children. The incidence of influenza and RSV hospitalization is well documented, but the incidence of medically attended, laboratory-confirmed illness has not been assessed in a well...

Descripción completa

Detalles Bibliográficos
Autores principales:	Simpson, Melissa D., Kieke, Burney A., Sundaram, Maria E., McClure, David L., Meece, Jennifer K., Sifakis, Frangiscos, Gasser, Robert A., Belongia, Edward A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2016
Materias:	Major Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4943552/ https://www.ncbi.nlm.nih.gov/pubmed/27419158 http://dx.doi.org/10.1093/ofid/ofw081

Ejemplares similares

Seasonal Incidence of Medically Attended Respiratory Syncytial Virus Infection in a Community Cohort of Adults ≥50 Years Old
por: McClure, David L., et al.
Publicado: (2014)

Clinical Features, Severity, and Incidence of RSV Illness During 12 Consecutive Seasons in a Community Cohort of Adults ≥60 Years Old
por: Belongia, Edward A, et al.
Publicado: (2018)

Prediction of serious RSV‐related outcomes in older adults with outpatient RSV respiratory illness during 12 consecutive seasons
por: Kieke, Burney A., et al.
Publicado: (2020)

Comparison of clinical features and outcomes of medically attended influenza A and influenza B in a defined population over four seasons: 2004–2005 through 2007–2008
por: Irving, Stephanie A., et al.
Publicado: (2011)

Impact of Late Oseltamivir Treatment on Influenza Symptoms in the Outpatient Setting: Results of a Randomized Trial
por: McLean, Huong Q., et al.
Publicado: (2015)

Clinical and virologic outcomes in patients with oseltamivir‐resistant seasonal influenza A (H1N1) infections: results from a clinical trial
por: Dharan, Nila J., et al.
Publicado: (2011)

Impact of Repeated Vaccination on Vaccine Effectiveness Against Influenza A(H3N2) and B During 8 Seasons
por: McLean, Huong Q., et al.
Publicado: (2014)

Relative Effectiveness of MF59 Adjuvanted Trivalent Influenza Vaccine vs Nonadjuvanted Vaccines During the 2019–2020 Influenza Season
por: Imran, Mahrukh, et al.
Publicado: (2022)

Influenza Vaccine Effectiveness in the United States During 2012–2013: Variable Protection by Age and Virus Type
por: McLean, Huong Q., et al.
Publicado: (2015)

Additional Burden Averted in the United States From Use of MF59-Adjuvanted Seasonal Influenza Vaccine Compared With Standard Seasonal Influenza Vaccine Among Adults ≥65 Years
por: McGovern, Ian, et al.
Publicado: (2023)

School absenteeism among school‐aged children with medically attended acute viral respiratory illness during three influenza seasons, 2012‐2013 through 2014‐2015
por: McLean, Huong Q., et al.
Publicado: (2017)

Streptococcus pyogenes Colonization in Children Aged 24–59 Months in the Gambia: Impact of Live Attenuated Influenza Vaccine and Associated Serological Responses
por: Keeley, Alexander J, et al.
Publicado: (2023)

Demand for Prophylaxis after Bioterrorism-Related Anthrax Cases, 2001
por: Belongia, Edward A., et al.
Publicado: (2005)

Respiratory Syncytial Virus Disease in Preterm Infants in the US Born at 32–35 Weeks Gestation Not Receiving Immunoprophylaxis
por: Ambrose, Christopher S., et al.
Publicado: (2014)

Adamantane-Resistant Influenza Infection During the 2004–05 Season
por: Rahman, Mahbubur, et al.
Publicado: (2008)

Safety and Immunogenicity of a ChAd155-Vectored Respiratory Syncytial Virus (RSV) Vaccine in Healthy RSV-Seropositive Children 12–23 Months of Age
por: Díez-Domingo, Javier, et al.
Publicado: (2022)

Impact of Statewide Program To Promote Appropriate Antimicrobial Drug Use
por: Belongia, Edward A., et al.
Publicado: (2005)

Clinician Knowledge and Beliefs after Statewide Program to Promote Appropriate Antimicrobial Drug Use
por: Kiang, Karen M., et al.
Publicado: (2005)

Characterization of Rare Spontaneous Human Immunodeficiency Virus Viral Controllers Attending a National United Kingdom Clinical Service Using a Combination of Serology and Molecular Diagnostic Assays
por: Khan, Maryam, et al.
Publicado: (2023)

1056 Factors Associated with Pre-season Seroprotection to B Lineage Influenza Viruses in Children
por: King, Jennifer, et al.
Publicado: (2014)

Transmission of Respiratory Syncytial Virus Infection Within Families
por: Heikkinen, Terho, et al.
Publicado: (2014)

Recurrent Respiratory Syncytial Virus Infection in a CD14-Deficient Patient
por: Besteman, Sjanna B, et al.
Publicado: (2022)

A cross-sectional analysis of symptom severity in adults with influenza and other acute respiratory illness in the outpatient setting
por: VanWormer, Jeffrey J, et al.
Publicado: (2014)

Epidemiology and Characteristics of Respiratory Syncytial Virus Pneumonia in Critically Ill Adults
por: Kim, Taeeun, et al.
Publicado: (2023)

Elevated Risk for HIV Infection among Men Who Have Sex with Men in Low- and Middle-Income Countries 2000–2006: A Systematic Review
por: Baral, Stefan, et al.
Publicado: (2007)

Hospitalizations for Respiratory Syncytial Virus Among Adults in the United States, 1997–2012
por: Pastula, Susan T., et al.
Publicado: (2017)

Estimation of the Number of Respiratory Syncytial Virus–Associated Hospitalizations in Adults in the European Union
por: Osei-Yeboah, Richard, et al.
Publicado: (2023)

Risk Factors and Medical Resource Utilization of Respiratory Syncytial Virus, Human Metapneumovirus, and Influenza-Related Hospitalizations in Adults—A Global Study During the 2017–2019 Epidemic Seasons (Hospitalized Acute Respiratory Tract Infection [HARTI] Study)
por: Falsey, Ann R, et al.
Publicado: (2021)

Severity of Respiratory Syncytial Virus Lower Respiratory Tract Infection With Viral Coinfection in HIV-Uninfected Children
por: Mazur, Natalie I., et al.
Publicado: (2017)

Phase 1/2a Safety and Immunogenicity of an Adenovirus 26 Vector Respiratory Syncytial Virus (RSV) Vaccine Encoding Prefusion F in Adults 18–50 Years and RSV-Seropositive Children 12–24 Months
por: Stuart, Arabella S V, et al.
Publicado: (2022)

N95 reprocessing by low temperature sterilization with 59% vaporized hydrogen peroxide during the 2020 COVID-19 pandemic
por: Jatta, Maimuna, et al.
Publicado: (2021)

Reduced Respiratory Syncytial Virus Load, Symptoms, and Infections: A Human Challenge Trial of MVA-BN-RSV Vaccine
por: Jordan, Elke, et al.
Publicado: (2023)

Racial Differences in Clinical Phenotype and Hospitalization of Blastomycosis Patients
por: Anderson, Jennifer L, et al.
Publicado: (2019)

Clinical Burden of Respiratory Syncytial Virus in Hospitalized Children Aged ≤5 Years (INSPIRE Study)
por: Hartmann, Katrin, et al.
Publicado: (2022)

Pediatric Respiratory Syncytial Virus Diagnostic Testing Performance: A Systematic Review and Meta-analysis
por: Onwuchekwa, Chukwuemeka, et al.
Publicado: (2023)

Insurance Status and the Risk of Severe Respiratory Syncytial Virus Disease in United States Preterm Infants Born at 32–35 Weeks Gestational Age
por: Franklin, Jeremy A., et al.
Publicado: (2016)

mRNA COVID‐19 vaccine effectiveness against SARS‐CoV‐2 infection in a prospective community cohort, rural Wisconsin, November 2020 to December 2021
por: McLean, Huong Q., et al.
Publicado: (2022)

Anemia in children aged 6 to 59 months attending a quaternary health facility in Maputo, Mozambique
por: Maulide Cane, R, et al.
Publicado: (2022)

Transmission of Respiratory Syncytial Virus Among Children Under 5 Years in Households of Rural Communities, the Philippines
por: Otomaru, Hirono, et al.
Publicado: (2019)

Impact of the Coronavirus Disease 2019 Pandemic on the Clinical Features of Pediatric Respiratory Syncytial Virus Infection in Japan
por: Ozeki, Shoko, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_f485vb4m5tne16evcv2pqhaiu2